UPMC Hillman Cancer Center at Butler Health System — Butler, Pennsylvania

Public research footprint of UPMC Hillman Cancer Center at Butler Health System, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8 · Lung Non-Small Cell Carcinoma · Anatomic Stage II Breast Cancer AJCC v8

Recently updated registry entries

NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)
NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability (Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UPMC Hillman Cancer Center at Butler Health System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.